| scholarly article | Q13442814 |
| P356 | DOI | 10.1183/13993003.00387-2017 |
| P698 | PubMed publication ID | 28529205 |
| P50 | author | Alimuddin Zumla | Q4726678 |
| Raquel Duarte | Q38544022 | ||
| Giovanni Battista Migliori | Q38804522 | ||
| Sergey E Borisov | Q39941882 | ||
| Selene Manga | Q114416108 | ||
| Domingo Juan Palmero | Q114416109 | ||
| Apostolos Papavasileiou | Q114416110 | ||
| Marie-Christine Payen | Q114416111 | ||
| Emanuele Pontali | Q114416112 | ||
| Pietro Viggiani | Q114416115 | ||
| Jai B Mullerpattan | Q124854140 | ||
| Giovanni Sotgiu | Q41436294 | ||
| Justin T Denholm | Q42217674 | ||
| Simon Tiberi | Q42399203 | ||
| Rosella Centis | Q53775535 | ||
| Gina Gualano | Q56394631 | ||
| Antonio Spanevello | Q56394633 | ||
| José-María García-García | Q56810207 | ||
| Luigi Codecasa | Q56850311 | ||
| Andrey Maryandyshev | Q56857214 | ||
| Jillian S Lau | Q59154047 | ||
| Mina Gaga | Q60777167 | ||
| Fabrizio Palmieri | Q62014463 | ||
| Laura Saderi | Q64138431 | ||
| Zarir Udwadia | Q76091841 | ||
| Carlos Manuel Da Silva Robalo Cordeiro | Q82317148 | ||
| Lia D'Ambrosio | Q88426741 | ||
| Jan-Willem C Alffenaar | Q88470065 | ||
| Margareth Dalcolmo | Q91606058 | ||
| Heinke Kunst | Q91638897 | ||
| Lina Davies Forsman | Q96012640 | ||
| O W Akkerman | Q99707604 | ||
| Evgeny Belilovski | Q114416104 | ||
| Alena Skrahina | Q114416105 | ||
| Alena Aleksa | Q114416106 | ||
| Judith Bruchfeld | Q114416107 | ||
| P2093 | author name string | Jerker Jonsson | |
| Keertan Dheda | |||
| Aliasgar Esmail | |||
| Katerina Manika | |||
| Federica Toscanini | |||
| Adrian R Tramontana | |||
| Paul Douglas | |||
| Pablo González Montaner | |||
| Varvara Solodovnikova | |||
| Jose A Caminero | |||
| Shashank Ganatra | |||
| Janina Artsukevich | |||
| Veronica White | |||
| Martin Enwerem | |||
| Tsetan Dorji Sadutshang | |||
| Mohammed Fadul | |||
| Suzette Oelofse | |||
| Alexey Filippov | |||
| Rohit Amale | |||
| Sonam Topgyal | |||
| Barbara Lazaro Mastrapa | |||
| Rodolfo Romero Leyet | |||
| Antonella Papalia | |||
| Isabel Carpena Martinez | |||
| Jorge Lazaro Teran Troya | |||
| Julia-Amaranta Garcia-Fuertes | |||
| Martina Ortelli | |||
| Tatsiana Sanukevich | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multicenter clinical trial | Q6934595 |
| P577 | publication date | 2017-05-21 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study | |
| P478 | volume | 49 |
| Q57026722 | A new era for treatment of drug-resistant tuberculosis |
| Q47237569 | A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis |
| Q64110153 | Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection |
| Q54249699 | Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress! |
| Q40113350 | Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis |
| Q90476765 | Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging |
| Q90304219 | Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis in the United States |
| Q89721792 | Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients |
| Q91302041 | Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial |
| Q49917864 | Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis |
| Q50508187 | Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India. |
| Q40080040 | Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review |
| Q53686366 | Delamanid for Rifampicin-Resistant Tuberculosis: A Retrospective Study from South Africa. |
| Q61447856 | Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/I |
| Q90988236 | Delamanid: does it have a role in tuberculosis treatment? |
| Q90465001 | Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis |
| Q49917841 | Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. |
| Q57294658 | Global TB Network: working together to eliminate tuberculosis |
| Q64096585 | Improved Fluoroquinolone-Resistant and Extensively Drug-Resistant Tuberculosis Treatment Outcomes |
| Q46959941 | Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis |
| Q91638969 | International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis |
| Q64069548 | Linezolid for drug-resistant pulmonary tuberculosis |
| Q89635117 | Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China |
| Q91638902 | Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation |
| Q47173840 | Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades |
| Q92236107 | Multidrug-resistant tuberculosis - Authors' reply |
| Q92325220 | Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs |
| Q61858045 | New Chromane-Based Derivatives as Inhibitors of Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies |
| Q55650643 | New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. |
| Q64071213 | New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents |
| Q64073637 | Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis |
| Q64081156 | Recent evidence on delamanid use for rifampicin-resistant tuberculosis |
| Q47105048 | Respiratory infection: insights from Assembly 10 of the European Respiratory Society 2017 Annual Congress |
| Q61387560 | Revising the definition of extensively drug-resistant tuberculosis |
| Q90673752 | Shortened tuberculosis treatment regimens: what is new? |
| Q64240244 | The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019 |
| Q64134549 | Transmission of drug-resistant tuberculosis in HIV-endemic settings |
| Q56888150 | Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis |
| Q92572130 | Tuberculosis |
| Q90040396 | Tuberculosis series 2020 |
| Q55711749 | Tuberculosis series. |
| Q52629914 | Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. |
Search more.